treatment employed both a novel sequential schedule of cisplatin ( usually in the evening ) 24 h before cyclophosphamide-doxorubicin and novel stepwise escalation , first of doxorubicin , then of hexamethylmelamine until either nadir white blood counts fell to 1000-1500/mm3 or platelets to 75,000-100,000/mm3 .
C0050385
cyclophosphamide-doxorubicin
C0013089
doxorubicin